Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. (2022)
Attributed to:
Respiratory infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2022.04.018
PubMed Identifier: 35405168
Publication URI: http://europepmc.org/abstract/MED/35405168
Type: Journal Article/Review
Volume: 84
Parent Publication: The Journal of infection
Issue: 6
ISSN: 0163-4453